Please login or sign up to post and edit reviews.
EpiPen Prices, the Clinton Foundation, and Lead Exposure - Publication Date |
- Aug 31, 2016
- Episode Duration |
- 00:55:31
Why did EpiPen's price skyrocket 400 percent over the past decade? Sarah and Matt dive into the complex world of American drug pricing to find out. Also on this episode: understanding why the Clinton Foundation gets so much scrutiny, and a white paper of the week that shows how problematic a small level of lead exposure can be.
Learn more about your ad choices. Visit
podcastchoices.com/adchoicesThis episode could use a review!
This episode could use a review! Have anything to say about it? Share your thoughts using the button below.
Submit Review